Literature DB >> 28774195

Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center.

James W Schurr1, Craig A Stevens2, Anne Bane3, Carol Luppi3, Sarah E Culbreth1, Amy Leigh Miller4,5, Jean M Connors5,6, Katelyn W Sylvester1.   

Abstract

Weight-based, nurse-driven heparin nomograms are reported in the medical literature to improve the time it takes to reach a minimum threshold for anticoagulation without compromising patient safety in specific indications or patient populations. This is the first report in the literature of an institution-wide protocol implementation and evaluation of effectiveness with simultaneous transition to an electronic health record. The purpose of implementing this practice change at our institution was to standardize practice, improve time to reach therapeutic anticoagulation, and improve patient safety. We conducted a retrospective analysis utilizing a pre/postimplementation design to compare outcomes. The primary end point evaluated was the time to reach minimum threshold value for therapeutic anticoagulation. Additionally, we assessed the percentage of patients who reached minimum threshold therapeutic anticoagulation within 24 hours, the percentage of patients with a critically supratherapeutic activated partial thromboplastin time (aPTT) value (≥120 seconds) during therapy, and a description of heparin titration for the first 4 aPTT results with nomogram use. Overall time to therapeutic anticoagulation decreased from a mean 18.7 to 11.7 hours (hazard ratio [HR] 1.59; 95% confidence interval 1.22-2.08; P < .0005). Percentage of patients receiving therapeutic anticoagulation within 24 hours increased from 74.4 to 88.5 (odds ratio [OR 2.97, P = .002) and the percentage of patients with an aPTT ≥120 seconds remained constant at 49.9 versus 46.8 (OR 0.92, P = .73). This practice change reduced time to therapeutic anticoagulation without an increase in the proportion of patients with a critically supratherapeutic aPTT at our institution.

Entities:  

Keywords:  anticoagulation; heparin; nomogram; titration

Mesh:

Substances:

Year:  2017        PMID: 28774195      PMCID: PMC6714682          DOI: 10.1177/1076029617721009

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  24 in total

1.  Preventing medication errors with smart infusion technology.

Authors:  Karen Wilson; Mark Sullivan
Journal:  Am J Health Syst Pharm       Date:  2004-01-15       Impact factor: 2.637

Review 2.  Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Authors:  J Hirsh; J E Dalen; D Deykin; L Poller
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

3.  Technological trends in health care: electronic health record.

Authors:  Sam Abraham
Journal:  Health Care Manag (Frederick)       Date:  2010 Oct-Dec

4.  Coagulation assays.

Authors:  Shannon M Bates; Jeffrey I Weitz
Journal:  Circulation       Date:  2005-07-26       Impact factor: 29.690

5.  A standard heparin nomogram for the management of heparin therapy.

Authors:  M K Cruickshank; M N Levine; J Hirsh; R Roberts; M Siguenza
Journal:  Arch Intern Med       Date:  1991-02

Review 6.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

Authors:  J Hirsh; T E Warkentin; S G Shaughnessy; S S Anand; J L Halperin; R Raschke; C Granger; E M Ohman; J E Dalen
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

7.  Nurse-driven intravenous heparin protocol: quality improvement initiative.

Authors:  Tanya D Williams; Katherine Sullivan; Christopher Lacey; Steve Adoryan; Brook Watts
Journal:  AACN Adv Crit Care       Date:  2010 Apr-Jun

8.  Effectiveness of a computerized system for intravenous heparin administration: using information technology to improve patient care and patient safety.

Authors:  Lance J Oyen; Rick A Nishimura; Narith N Ou; Jeffrey J Armon; Min Zhou
Journal:  Am Heart Hosp J       Date:  2005

9.  A controlled trial of smart infusion pumps to improve medication safety in critically ill patients.

Authors:  Jeffrey M Rothschild; Carol A Keohane; E Francis Cook; E John Orav; Elisabeth Burdick; Sarah Thompson; Judy Hayes; David W Bates
Journal:  Crit Care Med       Date:  2005-03       Impact factor: 7.598

10.  Optimal therapeutic level of heparin therapy in patients with venous thrombosis.

Authors:  R D Hull; G E Raskob; D Rosenbloom; J Lemaire; G F Pineo; B Baylis; J S Ginsberg; A A Panju; P Brill-Edwards; R Brant
Journal:  Arch Intern Med       Date:  1992-08
View more
  7 in total

1.  Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients.

Authors:  Andrew Frazer; James Rowland; Alison Mudge; Michael Barras; Jennifer Martin; Peter Donovan
Journal:  Eur J Clin Pharmacol       Date:  2019-09-11       Impact factor: 2.953

2.  Impact of Protocolized Pharmacist Intervention on Critical Activated Partial Thromboplastin Time Values With Heparin Infusions.

Authors:  Rachelle Barry; Craig A Stevens; Trina Huynh; Dmitri Lerner
Journal:  J Pharm Technol       Date:  2021-07-14

3.  Derivation and Validation of Age- and Body Mass Index-Adjusted Weight-Based Unfractionated Heparin Dosing.

Authors:  James W Schurr; Anne-Marie Muske; Craig A Stevens; Sarah E Culbreth; Katelyn W Sylvester; Jean M Connors
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

4.  Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin.

Authors:  Clara Ting; Katelyn W Sylvester; James W Schurr
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-13       Impact factor: 2.389

5.  Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy.

Authors:  Kevin McLaughlin; Jessica Rimsans; Katelyn W Sylvester; John Fanikos; David M Dorfman; Patricia Senna; Jean M Connors; Samuel Z Goldhaber
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

6.  Improving safety of unfractionated heparin: a retrospective, quasi-experimental, observational study of the impact of a pocket card and a computerised prescription aid tool in the University Hospitals of Geneva.

Authors:  Wedali E Jimaja; Jerome Stirnemann; Pierre Fontana; Katherine S Blondon
Journal:  BMJ Open       Date:  2022-03-15       Impact factor: 2.692

7.  Smart agent system for insulin infusion protocol management: a simulation-based human factors evaluation study.

Authors:  Michael A Rosen; Mark Romig; Zoe Demko; Noah Barasch; Cynthia Dwyer; Peter J Pronovost; Adam Sapirstein
Journal:  BMJ Qual Saf       Date:  2021-03-10       Impact factor: 7.035

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.